IP Library Patent Application 19261379
Patent Application
App. No. 19/261,379

SYSTEMS AND METHODS FOR LIBRARY PREPARATION ADAPTERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/261,379
Abstract

Provided herein are systems, methods, compositions, and kits for library preparation. In some cases, multiple distinct types of adapter molecules may be provided to a template nucleic acid molecule. In some cases, a single type of adapter molecule may be provided to a template molecule. In some cases, multiple distinct types of adapter molecules may be sequentially provided to a template molecule to form multi-adapter template complexes.

Claims (18)

1 .- 71 . (canceled)

72 . A kit comprising a plurality of non-naturally occurring nucleic acid molecules comprising at least eight non-naturally occurring nucleic acid molecules, wherein the at least eight non-naturally occurring nucleic acid molecules comprise sequences selected from any one of SEQ ID NOs: 205-1259.

73 . The kit of claim 72 , wherein the at least eight non-naturally occurring nucleic acid molecules further comprise a first strand comprising SEQ ID NO: 1.

74 . The kit of claim 73 , wherein the SEQ ID NO: 1 is disposed 5′ of a respective sequence selected from any one of SEQ ID NOs: 205-1259.

75 . The kit of claim 73 , wherein the SEQ ID NO: 1 is disposed 5′ of a reverse complementary sequence of a respective sequence selected from any one of SEQ ID NOs: 205-1259.

76 . The kit of claim 73 , wherein the at least eight non-naturally occurring nucleic acid molecules further comprises a second strand comprising SEQ ID NO: 2.

77 . The kit of claim 76 , wherein the SEQ ID NO: 2 is disposed 3′ of a respective sequence selected from any one of SEQ ID NOs: 205-1259.

78 . The kit of claim 76 , wherein the SEQ ID NO: 2 is disposed 3′ of a reverse complementary sequence of a respective sequence selected from any one of SEQ ID NOs: 205-1259.

79 . The kit of claim 72 , wherein a 3′ thymine of the at least eight non-naturally occurring nucleic acid molecules is phosphorylated.

80 . The kit of claim 72 , wherein each of the at least eight non-naturally occurring nucleic acid molecules comprises a different sequence selected from any one of SEQ ID NOs: 205-1259.

81 . The kit of claim 72 , wherein the plurality of non-naturally occurring nucleic acid molecules comprises at least 96 non-naturally occurring nucleic acid molecules, and wherein each of the at least 96 non-naturally occurring nucleic acid molecules comprises a different sequence selected from any one of SEQ ID NOs: 205-1259.

82 . The kit of claim 72 , wherein the plurality of non-naturally occurring nucleic acid molecules comprises at least 256 non-naturally occurring nucleic acid molecules, and wherein each of the at least 256 non-naturally occurring nucleic acid molecules comprises a different sequence selected from any one of SEQ ID NOs: 205-1259.

83 . A composition comprising a non-naturally occurring nucleic acid molecule comprising a first strand hybridized to a second strand, wherein the first strand comprises a sequence selected from any one of SEQ ID Nos 205-1259.

84 . The composition of claim 83 , wherein a 3′ thymine of the non-naturally occurring nucleic acid molecule is phosphorylated.

85 . The composition of claim 83 , wherein the first strand of the non-naturally occurring nucleic acid molecule further comprises SEQ ID No. 1260 positioned 5′ to the sequence selected from any one of SEQ ID NOs: 205-1259.

86 . The composition of claim 83 , wherein the non-naturally occurring nucleic acid molecule is further coupled to a template nucleic acid molecule.

87 . The composition of claim 83 , wherein the second stand comprises a reverse complementary sequence of the sequence selected from any one of SEQ ID NOs: 205-1259.

88 . The composition of claim 87 , wherein the second strand further comprises SEQ ID NO: 2 positioned 3′ to the reverse complementary sequence.

Assignments (1)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →